These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 26549031)
1. Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer. Shigeta S; Toyoshima M; Kitatani K; Ishibashi M; Usui T; Yaegashi N Oncogene; 2016 Jul; 35(27):3577-86. PubMed ID: 26549031 [TBL] [Abstract][Full Text] [Related]
3. Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis. Huang HS; Chu SC; Hsu CF; Chen PC; Ding DC; Chang MY; Chu TY Carcinogenesis; 2015 Nov; 36(11):1419-28. PubMed ID: 26363031 [TBL] [Abstract][Full Text] [Related]
4. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
5. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616 [TBL] [Abstract][Full Text] [Related]
6. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related]
7. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900 [TBL] [Abstract][Full Text] [Related]
8. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma. de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239 [TBL] [Abstract][Full Text] [Related]
9. Tubal origin of ovarian cancer - the double-edged sword of haemoglobin. Lin SF; Gerry E; Shih IM J Pathol; 2017 May; 242(1):3-6. PubMed ID: 28054715 [TBL] [Abstract][Full Text] [Related]
10. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas]. Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711 [TBL] [Abstract][Full Text] [Related]
11. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma]. Xiang L; Li J; Wang LJ; Zheng WX; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344 [TBL] [Abstract][Full Text] [Related]
12. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma]. Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294 [No Abstract] [Full Text] [Related]
13. Non-neoplastic Fallopian Tube Epithelium Carrying Gene Mutations of a Novel SOX2 Repressor Region is Soil of High-grade Serous Ovarian Cancer. Hirohashi Y; Torigoe T EBioMedicine; 2016 Aug; 10():17-8. PubMed ID: 27423191 [No Abstract] [Full Text] [Related]
15. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers. Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744 [TBL] [Abstract][Full Text] [Related]
16. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers. Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882 [TBL] [Abstract][Full Text] [Related]
17. Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions. Wu NY; Fang C; Huang HS; Wang J; Chu TY Mod Pathol; 2020 Jan; 33(1):29-37. PubMed ID: 31558785 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983 [TBL] [Abstract][Full Text] [Related]
19. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912 [TBL] [Abstract][Full Text] [Related]